Oxymorphone hydrochloride
These highlights do not include all the information needed to use OXYMORPHONE hydrochloride Extended-Release Tablets safely and effectively. See full prescribing information for OXYMORPHONE hydrochloride Extended-Release Tablets. OXYMORPHONE hydrochloride Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 1959
e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde
HUMAN PRESCRIPTION DRUG LABEL
Sep 13, 2016
Ranbaxy Pharmaceuticals Inc.
DUNS: 937890044
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Oxymorphone hydrochloride
Product Details
FDA regulatory identification and product classification information